舒适护理对冠状动脉支架植入患者生活质量的干预作用被引量：4

The intervention effect of comfort care on the quality of life in patients with coronary stent implantation

下载PDF

导出

摘要目的:探讨舒适护理对冠状动脉支架植入(CASI)患者生活质量的干预作用。方法:收集经CASI治疗的冠心病患者72例,按照随机数字表法分为对照组与观察组各36例。观察组与对照组患者入院后均给予入院评估、病情观察、饮食护理、术前准备及术后护理等常规护理方法,观察组在常规护理的基础上对患者实施舒适护理。评价2组患者治疗前后的焦虑、抑郁情绪及治疗后的生活质量。结果:观察组患者术后生理功能、心理状态、社会关系、独立性、环境和总生活质量的评分均高于对照组(P<0.05);术后第15、30天观察组的焦虑、抑郁评分较对照组改善更为明显(P<0.05)。结论:舒适护理能缓解CASI患者的焦虑、抑郁情绪,提高患者生活质量。 Objective：To investigate the intervention effects of comfort care on the quality of life in patients with coronary stent implantation. Methods：Seventy-two patients with coronary heart disease were divided into the observation group and control group using the random number table method（36 cases each group）. The conventional measures,which included admission assessment,condition observation,diet care and preoperative and postoperative preparation,in two groups were implemented,and the observation group were additionally treated with comfort care mode. The anxiety and depression before and after treatment,and the quality of life after treatment in two groups were evaluated. Results： The scores of postoperative physical function,psychological state,social relationship,independence,environment and overall quality of life in observation group were significantly higher than those in control group after operation（P〈0. 05）. Compared with the control group,the scores of the anxiety and depression in observation group were significantly improved at 15 and 30 days after operation（P〈0. 05）. Conclusions：Comfort care can relieve the anxiety and depression,and improve quality of life of patients with coronary stent implantation.

作者陈晓莎

机构地区川北医学院附属第二医院(四川绵阳四零四医院)心血管内科

出处《蚌埠医学院学报》 CAS 2014年第8期1126-1129,共4页 Journal of Bengbu Medical College

关键词心脏病冠状动脉支架植入舒适护理生活质量 heart disease coronary stent implantation comfort care quality of life

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献11

1Mehta RH, Harjai KJ, Boura JA, et al.Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention:Implications for patients requiring early coronary artery bypass surgery[J].Am Heart J, 2013, 165(6):1000-1007.
2Kereiakes DJ, Sudhir K, Cristea E, et al.Evaluation of XIENCE Ⅴ everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT Ⅳ trial at 2 years[J].Am J Cardiol, 2013, 111(11):1580-1586.
3Abdel-Wahab M, Richardt G, Joachim Büttner H, et al.High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions:the randomized ROTAXUS(Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial[J].JACC Cardiovasc Interv, 2013, 6(1):10-19.
4Lee BK, Kim YH, Park DW, et al.Acute and long-term angiographic outcomes of side branch stenosis after randomized treatment of zotarolimus-, sirolimus-, and paclitaxel-eluting stent for coronary artery stenosis[J].J Korean Med Sci, 2012, 27(12):1499-1506.
5Markovic S, Paliskyte R, Rottbauer W, et al.Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses[J].Cardiovasc Revasc Med, 2012, 13(6):307-310.
6Flather M, Rhee JW, Boothroyd DB, et al.The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease.A collaborative analysis of individual patient data from 10 randomized trials[J].J Am Coll Cardiol, 2012, 60(21):2150-2157.
7Latib A, Colombo A, Castriota F, et al.A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels:the BELLO(Balloon Elution and Late Loss Optimization) study[J].J Am Coll Cardiol, 2012, 60(24):2473-2480.
8Diletti R, Serruys PW, Farooq V, et al.ABSORB Ⅱ randomized controlled trial:a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions:rationale and study design[J].Am Heart J, 2012, 164(5):654-663.
9Tokushige A, Shiomi H, Morimoto T, et al.Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation:a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2[J].Cardiovasc Interv Ther, 2013, 28(1):45-55.
10Camenzind E, Wijns W, Mauri L, et al.Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation:a randomised, multicentre, open-label, controlled trial[J].Lancet, 2012, 380(9851):1396-1405.